Hutchison China Meditech Limited Director's Share Dealing (4283P)
31 August 2017 - 7:15PM
UK Regulatory
TIDMHCM
RNS Number : 4283P
Hutchison China Meditech Limited
31 August 2017
Director's Share Dealing
London: Thursday, August 31, 2017: Hutchison China MediTech
Limited ("Chi-Med") (AIM/Nasdaq: HCM) has received notifications
that Mr Simon To, Executive Director and Chairman, through Dynamic
Drive Limited, a person closely associated with Mr To, purchased a
total of 14,748 American Depositary Shares of the Company ("ADSs",
each representing one half of one ordinary share of US$1.00 each in
the capital of Chi-Med) on August 28 and 29, 2017 at an average
price of US$24.40 per ADS. Dynamic Drive Limited is controlled by
the trustee of Dynamic Drive Trust (the "DDT") which has been
established for the benefit of Mr To's family members, of which Mr
To is the settlor.
Following the above purchases, Mr To is interested in 133,237
ADSs (in DDT and Wencheng Trust of which his family members are the
beneficiaries) and 180,000 Ordinary Shares (including the holding
of 78,000 Ordinary Shares in DDT of which his family members are
the beneficiaries), representing in aggregate approximately 0.41%
of the current issued share capital of Chi-Med.
The notification set out below is provided in accordance with
the requirements of the EU Market Abuse Regulation.
1 Details of the person discharging managerial responsibilities/person closely associated
----- ---------------------------------------------------------------------------------------------------------------
a) Name Dynamic Drive Limited
----- ------------------------------------ -------------------------------------------------------------------------
2 Reason for the notification
----- ---------------------------------------------------------------------------------------------------------------
a) Position/status Person closely associated with Mr Simon To, Executive Director and
Chairman. Dynamic Drive
Limited is controlled by the trustee of Dynamic Drive Trust which has
been established for
the benefit of Mr To's family members, of which Mr To is the settlor.
----- ------------------------------------ -------------------------------------------------------------------------
b) Initial notification/Amendment Initial notification
----- ------------------------------------ -------------------------------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
----- ---------------------------------------------------------------------------------------------------------------
a) Name Hutchison China MediTech Limited
----- ------------------------------------ -------------------------------------------------------------------------
b) LEI 2138006X34YDQ6OBYE79
----- ------------------------------------ -------------------------------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
----- ---------------------------------------------------------------------------------------------------------------
a) Description of the financial ADS each representing one half of one Ordinary Share of US$1.00
instrument, type of instrument ADS ISIN: US44842L1035
Identification code
----- ------------------------------------ -------------------------------------------------------------------------
b) Nature of the transaction Acquisition of a total of 14,748 ADSs in the name of Dynamic Drive
Limited which holds the
ADSs for a family trust (Dynamic Drive Trust) of which Mr To is the
settlor on August 28 and
29, 2017 at an average price of US$24.40 per ADS.
----- ------------------------------------ -------------------------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
----- ------------------------------------ ------------------------------------ -----------------------------------
US$24.47 5,554
------------------------------------------------------------------------------- -----------------------------------
US$24.36 9,194
------------------------------------------------------------------------------- -----------------------------------
d) Aggregated information Aggregated volume: 14,748 ADSs
- Aggregated volume Price information: US$24.40
- Price
----- ------------------------------------ -------------------------------------------------------------------------
e) Date of the transaction 2017-08-28 - acquisition of 5,554 ADSs
2017-08-29 - acquisition of 9,194 ADSs
----- ------------------------------------ -------------------------------------------------------------------------
f) Place of the transaction Nasdaq Stock Market
----- ------------------------------------ -------------------------------------------------------------------------
About Chi-Med
Chi-Med is an innovative biopharmaceutical company which
researches, develops, manufactures and sells pharmaceuticals and
healthcare products. Its Innovation Platform, Hutchison MediPharma
Limited, focuses on discovering and developing innovative
therapeutics in oncology and autoimmune diseases for the global
market. Its Commercial Platform manufactures, markets, and
distributes prescription drugs and consumer health products in
China.
Chi-Med is majority owned by the multinational conglomerate CK
Hutchison Holdings Limited ("CK Hutchison") (SEHK: 0001). For more
information, please visit: www.chi-med.com.
CONTACTS
Investor Enquiries
Mark Lee,
SVP Corporate Finance & Development +852 2121 8200
U.K. & International Media Enquiries
Anthony Carlisle, Citigate Dewe Rogerson +44 7973 611 888 (Mobile) anthony.carlisle@cdrconsultancy.co.uk
U.S. Based Media Enquiries
Brad Miles, BMC Communications +1 (917) 570 7340 (Mobile) bmiles@bmccommunications.com
Susan Duffy, BMC Communications +1 (917) 499 8887 (Mobile) sduffy@bmccommunications.com
Investor Relations
Matt Beck, The Trout Group +1 (917) 415 1750 (Mobile) mbeck@troutgroup.com
David Dible, Citigate Dewe Rogerson +44 7967 566 919 (Mobile) david.dible@citigatedr.co.uk
Panmure Gordon (UK) Limited
Richard Gray / Andrew Potts +44 (20) 7886 2500
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLIFIATLILVID
(END) Dow Jones Newswires
August 31, 2017 05:15 ET (09:15 GMT)
Hutchmed (china) (LSE:HCM)
Historical Stock Chart
From Apr 2024 to May 2024
Hutchmed (china) (LSE:HCM)
Historical Stock Chart
From May 2023 to May 2024